We investigated the dose-dependent therapeutic effectiveness of AT1R antagonism alone or in combination with NEP inhibition on AngII-induced cardiovascular responses of hypertension, atherosclerosis, and AAA formation in hypercholesterolemic mice. Here, AGTR1 is linked to triple-A syndrome.